Sorafenib BRAF (gene)
figure 3: b-raf kinase domain locked in inactive conformation bound bay43-9006. hydrophobic interactions anchor bay43-9006 in atp binding site while urea group hydrogen-bonding traps d594 of dfg motif. bay43-9006 trifluoromethyl phenyl ring further prohibits dfg motif , activation loop movement active confermer via steric blockage.
bay43-9006 (sorafenib, nexavar)is v600e mutant b-raf , c-raf inhibitor approved fda treatment of primary liver , kidney cancer. bay43-9006 disables b-raf kinase domain locking enzyme in inactive form. inhibitor accomplishes blocking atp binding pocket through high-affinity kinase domain. binds key activation loop , dfg motif residues stop movement of activation loop , dfg motif active conformation. finally, trifluoromethyl phenyl moiety sterically blocks dfg motif , activation loop active conformation site, making impossible kinase domain shift conformation become active.
the distal pyridyl ring of bay43-9006 anchors in hydrophobic nucleotide-binding pocket of kinase n-lobe, interacting w531, f583, , f595. hydrophobic interactions catalytic loop f583 , dfg motif f595 stabilize inactive conformation of these structures, decreasing likelihood of enzyme activation. further hydrophobic interaction of k483, l514, , t529 center phenyl ring increase affinity of kinase domain inhibitor. hydrophobic interaction of f595 center ring decreases energetic favorability of dfg conformation switch further. finally, polar interactions of bay43-9006 kinase domain continue trend of increasing enzyme affinity inhibitor , stabilizing dfg residues in inactive conformation. e501 , c532 hydrogen bond urea , pyridyl groups of inhibitor respectively while urea carbonyl accepts hydrogen bond d594 s backbone amide nitrogen lock dfg motif in place.
the trifluoromethyl phenyl moiety cements thermodynamic favorability of inactive conformation when kinase domain bound bay43-9006 sterically blocking hydrophobic pocket between αc , αe helices dfg motif , activation loop inhabit upon shifting locations in active conformation of protein.
Comments
Post a Comment